Tuesday, October 27, 2026

EQT Q3 FY12/26 Earnings Review - Distribute Rating

EQT moved to Distribute at $56.29 after Q3 revenue fell 9.6%; a 44% trailing free-cash-flow margin signals cycle risk despite lower debt and an EPS beat.

EQT $34B

Cestrian Capital Research Oct 27 2 clicks

Oct 27 GFL $16B

My Last GFL Update - Hopefully

310 Value’s Newsletter 5 clicks

Oct 27 LITE $62B

Expert Call | Lumentum Optical Chip Capacity, EML/SiPh Outlook & Industry Pricing

P Equity Research 2 clicks

From X

@ACapitalLP Oct 27

A Capital on X

@310Value You don’t like the long $CWST / short $GFL pair trade? Nothing like shorting a live take-private situation to hedge an activist margin improvement story.

@ACapitalLP Oct 27

A Capital on X

@richtrades100 Isn’t it worse now that $MGM stock is lower and $PPLI is higher? Have to issue more stock as currency…

@StableBread Oct 27 2 clicks

Fajasy on X

@babyfolio @StonkChris Havent dug in much but from what i seen and heard market seems to be real wrong om $CBRS

@ACapitalLP Oct 27 1 click

A Capital on X

@KEDM_COM These guys are also in $ZD - Czech based activist fund?

@BarbarianCap Oct 27 2 clicks

Barbarian Capital on X

Robinhood quarterly revenue rises 12% as event contracts, options offset crypto slump $HOOD https://t.co/OuqJoAA9Fy

@ParadisLabs Oct 27 1 click

Paradis on X

A lot of green in AI land today from $NBIS +11.2% to $CRDO +10.8%. Over the past few weeks, financing has been the main pressure point but it seems like we've made some solid progress this week. - $META raised $97.5B, with $60B of that coming through an ATM starting in January. - $SPCX signed a $40B deal for GPU equipment. - $AVGO set up a $63B SPV to fund custom chips for Anthropic, who also eased some fears with their S-1. Feels like the rapid de-grossing over the last few weeks has mostly run its course, however according to JPM, volumes still remain light. Interestingly, GS say that there's evidence today of "increased offense being played across the AI complex". While this is still minimal, it's a notable uptick vs. the past few weeks where risk was near zero. I wonder whether the market decides to pay attention to the upcoming hurdles, or whether it keeps riding the wall of worry higher. I personally still land on some short-term choppiness when you consider how bruised investors have gotten since July + hurdles in the next few days (hyperscaler earnings, FOMC, midterms).

@Mr_Neutral_Man Oct 27

Mr Neutral Man aka "Howard Marks of REITs” on X

Only one stock is down double digits in both the 1st and 2nd half $CHTR https://t.co/knuRdXweGS

@eriksen_tim Oct 27

Tim Eriksen on X

@ericgold34 Been buying $UBAB lately. A few I have not followed closely. Some are very illiquid.

Novartis (NYSE: NVS) Stock Rating: Do Nothing After Q3 FY12/26 Earnings

Novartis grew Q3 sales 4% to $14.5bn and raised profit guidance, but pipeline failures triggered a $1.9bn impairment as net debt reached…

NVS $304B

Cestrian Capital Research Oct 27 3 clicks

AppFolio 3Q26 Business Recap: AI Agents Support Growth

AppFolio grew third-quarter revenue 19% as Realm-X AI agents gained adoption, lifting guidance to $1.122 billion to $1.127 billion.

APPF $7.6B

Speedwell Research Oct 27 5 clicks

Boeing (NYSE: BA) Stock Rating: Do Nothing After Q3 FY12/26 Earnings

Boeing posted $24.2 billion in Q3 revenue and $1.5 billion in operating cash flow, but commercial aircraft lost $697 million as production…

BA $136B

Cestrian Capital Research Oct 27 1 click

TTM Technologies: The Market Already Caught On To Peak Numbers

TTM Technologies’ record Q3 and data-center exposure drove a 27.7% stock drop as investors questioned debt-funded growth, leverage and the…

TTMI $8.6B

Nicolas Bolsinger Oct 27 1 click

Are Neoclouds Dead?

Neoclouds face tighter debt financing as AI infrastructure capex outruns cash flow, leaving cash-burning GPU providers more exposed than…

NBIS $42B

Daniel Romero Oct 27 9 clicks

Quantinuum: A Quantum Leader At A Reasonable Value

Quantinuum’s trapped-ion quantum platform supports a $2 billion 2030 revenue estimate and $135 fair value, backed by $2.1 billion cash and…

QNT $1.2B

Fundamental Options Oct 27 5 clicks

Reddit: Deep Dive Analysis

Reddit generated $805 million in Q2 2026 revenue, 95% from ads, but slowing Google search referrals expose AI-driven traffic and…

RDDT $18B

Hated Moats Oct 27 6 clicks

Qualcomm Inc. (QCOM)

Qualcomm supplies chips for on-device AI agents and data center inference, with Meta and AWS agreements expanding its role across both…

QCOM $195B

SixSigmaCapital: Navigating the Financial Markets Oct 27 5 clicks

Single Stock Spotlight #17: Gamestop (GME)

GameStop’s $6.1 billion in net cash equivalents and shift toward collectibles underpin a $30 to $40 per-share valuation thesis.

GME $12B

Hidden Rock Capital's Newsletter Oct 27 4 clicks

Monte Investments Market Brief Vol. CXXXIII

Monte Investments updates Carpenter Technology after a 25% sell-off, tracks EQT’s $12.83 billion Range Resources acquisition and assesses…

CRS $15BKRMN $5.2B

Monte Independent Investment Research Oct 27 1 click

VEEV · long

Veeva Systems INC

Veeva Systems is a vertical software company valued as if its best growth years are behind it.

VEEV $49B

Value Investors Club Jul 9

A special situation bet on the power of incentives with 10x upside in a mandated year timeframe.

Beasley Broadcast Group's equity hinges on repaying or arranging sales for roughly $115.5 million of debt by September 2027, before PIK…

BBGI $13M

Calvin Blissett Sep 17 2 clicks

Progyny: Best-In-Class And Likely To Exceed Analyst Estimates In 2027

Progyny's Q2 revenue rose 11% excluding Amazon, with margin expansion and nearly 100% EPS growth guidance for 2026 supporting…

PGNY $2.3B

Robert J. Lake Sep 17

Problems at Jackson Financial ($JXN)

Jackson Financial administers $287 billion in retirement accounts while a report says its captive, hedge-loss installment plan and…

JXN $9.4B

Hunterbrook Sep 17 4 clicks

Copart 4Q26 Business Update

Copart's U.S. insurance volumes fell 7.5% in 4Q26, largely from one customer loss, while international insurance units rose 11.2% and…

CPRT $27B

Speedwell Memos Sep 17 3 clicks

Viridian Therapeutics: Two Products, One Commercial Buildout

Viridian Therapeutics is building a shared commercial platform for Lumvoa and investigational elegrobart in thyroid eye disease, with…

VRDN $2.8B

Equity Eagle Sep 17

Thursday Tailwinds #7: Sep 17, 2026

Turning Point Brands awaits FDA pouch approval, Meitec benefits from Japan’s engineer shortage, and Viemed gains from Medicare’s…

TPB $1.4BVMD $360M

Trade Ideas Flow Sep 17

Vizsla Silver (VZLA)

Vizsla Silver's Panuco project in Sinaloa remains shut after nine workers were found dead, delaying construction of a fully funded 17.4 Moz…

VZLA $1.6B

Triple S Special Situations Investing Sep 17 1 click

Figure Technology (FIGR): The "Hypoport of America" Growing 100% With 55% EBITDA Margins – and Priced Like the Story Is Broken

Figure Technology's HELOC platform grew Q2 2026 revenue 113% with a 54.6% adjusted EBITDA margin, while shares trade 57% below January's…

FIGR $4.9B

Substack von Philipp Sep 17 8 clicks

Vistra: Q2 2026 Confirmed The AI Power Scarcity Problem

Vistra’s Q2 2026 results reinforce its PJM and ERCOT generation advantage as AI data-center demand tightens power supply, supported by…

VST $46B

The Curious Analyst Sep 17 1 click

Tuesday, October 27, 2026

A Capital on X

A Capital on X

Fajasy on X

A Capital on X

Barbarian Capital on X

Paradis on X

Mr Neutral Man aka "Howard Marks of REITs” on X

Tim Eriksen on X

Investor Letters

Publications we follow

Newsletters 109

YouTube 4

Blogs 15

Seeking Alpha 69 of 272

X accounts we follow

Investor letters we follow

Sectors